Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06793007Completed

Variants Of Intrahepatic Biliary Radicals in Nepali Population

Role: lead

NCT06751420Completed

Circle of Willis Variants in Nepali Population Evaluated in TOF MR Angiography

Role: lead

NCT06683859Completed

Variants of Paranasal Sinuses in Nepali Population

Role: lead

NCT06077929Completed

Optic Nerve Course Variants in Nepali Population

Role: lead

NCT06434675Completed

Prevalence of Variants of Nasal Cavity and Nasal Septum in Nepalese

Role: lead

NCT06251440Completed

Initial Experience of Transabdominal Fetal Reduction in Nepal

Role: lead

All 6 trials loaded